How do you approach the treatment of de novo, brain only metastatic HER2 positive breast cancer?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of North Carolina School of Medicine
Would anyone use tucatinib+tras+/-xeloda based on ...
Medical Oncologist at University of Texas MD Anderson Cancer Center
It is appealing to add cytotoxic therapy in a situ...
Medical Oncologist
Would this maintenance period of HP be long term v...
Medical Oncologist at University of Texas MD Anderson Cancer Center
For patients with metastatic disease, the conventi...
Sign in or Register to read more